These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 48661)

  • 1. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M; Ramot B
    Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F; Verhaegen-Declercq M; Brugmans J
    Lancet; 1975 Apr; 1(7913):978. PubMed ID: 48151
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B; Biniaminov M; Shoham C; Rosenthal E
    N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of thymus dependent lymphocytes in Hodgkin's disease.
    Andersen E
    Scand J Haematol; 1974; 12(4):263-9. PubMed ID: 4545783
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Lymphocytes in spleen in Hodgkin's disease.
    Grifoni V; Del Giacco GS; Manconi PE; Tognella S; Mantovani G
    Lancet; 1975 Feb; 1(7902):332-3. PubMed ID: 46472
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of levamisole in Hodgkin's disease.
    Berényi E; Sonkoly I; Kávai M; Szabolcsi M; Szegedi G
    N Engl J Med; 1977 Apr; 296(16):941. PubMed ID: 846517
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of advanced Hodgkin's disease in remission.
    Klener P; Hausner P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: T and B lymphocytes in spleen in Hodgkin's disease.
    Joseph RR; Belpomme D
    Lancet; 1975 Mar; 1(7909):747-8. PubMed ID: 47511
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum factors and T lymphocytes in Hodgkin's disease: correction.
    N Engl J Med; 1977 Mar; 296(11):630. PubMed ID: 320473
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of B and T lymphocytes in the peripheral blood of patients with Hodgkin's disease.
    Many A; Biniaminov M; Rosenthal E; Aghai E; Ramot B
    Acta Haematol; 1976; 56(1):1-6. PubMed ID: 822670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
    Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
    Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosette-forming lymphocytes in Hodgkin's disease.
    Cohnen G; Augener W; Brittinger G; Douglas SD
    N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosette formation in Hodgkin's disease.
    Swain A; Trounce JR
    Oncology; 1974; 30(6):449-57. PubMed ID: 4549695
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Surface characteristics of Hodgkin's lymphoma cells.
    Braylan RC; Jaffe ES; Berard CW
    Lancet; 1974 Nov; 2(7892):1328-9. PubMed ID: 4139576
    [No Abstract]   [Full Text] [Related]  

  • 19. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP; Danilova NV
    Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T and B blocking factors in Hodgkin's disease.
    Bentwich R; Cohen R; Brautbar C
    Adv Exp Med Biol; 1976; 66():685-90. PubMed ID: 1083664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.